A Rationally Designed Complex Replenishes the Transferrin Iron Pool Directly and with High Specificity

Area of Science:

• Biochemistry
• Pharmacology
• Hematology

Background:

• Anemia is often caused by impaired iron (Fe) transport due to reduced ferroportin activity.
• This ferroportin dysfunction limits iron delivery to bone marrow, complicating anemia treatment.
• Current iron supplementation methods face challenges due to the ferroportin-transferrin axis.

Purpose of the Study:

• To design and evaluate a novel iron complex (Fe-BBG) for targeted iron replenishment.
• To optimize Fe-BBG's properties for rapid and precise iron delivery to transferrin.
• To assess Fe-BBG's efficacy and safety in an anemia model.

Main Methods:

• Coordination chemistry principles were used to design the Fe-BBG complex.
• Solution thermodynamics and iron dissociation kinetics were optimized.
• Fe-BBG efficacy was tested in a mouse model of iron-refractory iron-deficiency anemia.
• Safety was assessed by monitoring clinical chemistry and gene expression related to oxidative stress and inflammation.

Main Results:

• Fe-BBG demonstrated optimized thermodynamics and kinetics for rapid transferrin iron replenishment.
• The complex was unreactive towards redox cycling and reactive oxygen species production.
• Fe-BBG successfully corrected anemia in a mouse model.
• No adverse clinical chemistry changes or signs of oxidative stress/inflammation were observed.

Conclusions:

• Fe-BBG represents a new class of transferrin-targeted iron replacement drugs.
• This approach effectively bypasses ferroportin-mediated iron transport limitations.
• Fe-BBG shows promise as a safe and effective therapeutic for specific anemias.